Elevation of tissue α-tocopherol levels by conjugated linoleic acid in C57BL/6J mice is not associated with changes in vitamin E absorption or α-carboxyethyl hydroxychroman production

Nutrition. 2012 Jan;28(1):59-66. doi: 10.1016/j.nut.2011.04.006. Epub 2011 Aug 27.

Abstract

Objective: Conjugated linoleic acid (CLA) decreases adipose mass and increases vitamin E levels in the liver and adipose tissue in mice. The aim of the present study was to examine the mechanism by which CLA alters vitamin E levels in tissues and antioxidant activity in mice.

Methods: C57BL/6J mice were divided into three groups and fed 5% lipid as soybean oil alone (control group), 4% soybean oil supplemented with 1% CLA (CLA group), or 5% lipid with a vitamin E supplement (VE group) for 4 wk.

Results: The CLA and VE diets resulted in a significant increase in the α-tocopherol concentration in all tissues examined, i.e., the liver, kidney, testis, spleen, heart, lung, and adipose tissue (P < 0.05). Levels of thiobarbituric acid-reactive substances in the kidney, testis, heart, lung, and adipose tissue were lower in the CLA and VE groups than in the control group (P < 0.05). CLA did not alter the absorption rate of vitamin E or α-carboxyethyl hydroxychromans levels in the liver and plasma. The CLA diet induced a significant increase in α-tocopherol transfer protein and mRNA levels in the liver. CLA resulted in a decrease in catalase and glutathione peroxidase activities and peroxisome proliferator α mRNA levels but had no effect on levels of mRNAs for other nuclear transcription factors in the liver.

Conclusion: The increase in vitamin E status in CLA-fed mice is not due to altered absorption and metabolism of vitamin E but might be related to the induction of α-tocopherol transfer protein expression in the liver. The regulation of the activities of catalase and glutathione peroxidase by CLA is not mediated by vitamin E accumulation in the liver.

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Chromans / blood
  • Chromans / metabolism
  • Dietary Supplements*
  • Gene Expression Regulation*
  • Hypolipidemic Agents / therapeutic use*
  • Intestinal Absorption
  • Linoleic Acids, Conjugated / therapeutic use*
  • Liver / enzymology
  • Liver / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Oxidoreductases / genetics
  • Oxidoreductases / metabolism
  • PPAR alpha / genetics
  • PPAR alpha / metabolism
  • RNA, Messenger / metabolism
  • Thiobarbituric Acid Reactive Substances / metabolism
  • Triglycerides / blood
  • alpha-Tocopherol / blood
  • alpha-Tocopherol / metabolism*

Substances

  • Antioxidants
  • Carrier Proteins
  • Chromans
  • Hypolipidemic Agents
  • Linoleic Acids, Conjugated
  • PPAR alpha
  • RNA, Messenger
  • Thiobarbituric Acid Reactive Substances
  • Triglycerides
  • alpha-tocopherol transfer protein
  • carboxyethyl-hydroxychroman
  • Oxidoreductases
  • alpha-Tocopherol